NeoGenomics Announces Entry Into Flow Cytometry Testing Market

NeoGenomics has received all regulatory approvals to offer flow cytometry testing services and has formally entered this market. Flow cytometry uses sophisticated laser-based equipment to analyze cell surface markers and is very effective at diagnosing certain types of cancer.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050209005148&newsLang=en)